{"name":"Novelty Nobility, Inc.","slug":"novelty-nobility-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE9tX2ZGbkdINjNJbmpBOWtVMG1mbXVCVmNZMlNQS21ObU96bk5MaGFJc3JSalpyR0ptNzgyVWIwNnRoN0ZiTktLOThkeU5IcFhQcWthLW1LVXdSbjRCOXd6d0RyTS1yV2xmbkx5cEFR0gFyQVVfeXFMUDIxYzVIdHl0Z1pDOTdvUDdxNl8tbEQ3bEhKa1FCVy1xTTdYR2JsMXptVUFYNXBtMUoxRko2ODkzUDVFc2phS3FrS0lrU2Y0aEtHeDBsSV9xQ2x6dF9hOTNXMTUwUzloNjBtd3JRN1ZuY1F3?oc=5","date":"2025-08-25","type":"deal","source":"koreabiomed.com","summary":"KOAS seeks to acquire antibody drug developer Novelty Nobility - koreabiomed.com","headline":"KOAS seeks to acquire antibody drug developer Novelty Nobility","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxNcnFDYlR6Y1VGV3VrYy10VVBpUTMyVUlIa19DRmRuY2pIcmIxX2ctMDRhOGlaOXZPVjNzdjNfR0pLQjRvcHZONFhJTmtva3d1QWZ0MlR2WFlHbThsMTBwWGdPRWsxUGh6T1RibzFLaHZpOGI3MkFJWHo0NDhzbC04c2xXaXd2N0tiTXY2cUNjRG1GbUZnYXpJ?oc=5","date":"2025-05-27","type":"deal","source":"Contract Pharma","summary":"Lilly Agrees to Acquire SiteOne Therapeutics - Contract Pharma","headline":"Lilly Agrees to Acquire SiteOne Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxQMWRCd0hGeENtNmtxckRmTkxJZ3NkZ2ZsakVsbjBKRVYyMHZNcTNhRElYaFZfeTFEbURFdFUxV19rTVZDeVptYmV1cEU1VFk1ZUhKV3JBeEJPM1YyQV9LX2V5SEpTRS1DS0V5TEdjcmtXaUg1alFlZnc5NWJLMTcxNHlTMC1BMXdoY1RiM3NicGMwSDVBV0FjV2JrNjl6QlV3MVV1VnJXc1lqUzZ3LXE4?oc=5","date":"2025-05-06","type":"deal","source":"Contract Pharma","summary":"AGC Biologics & Novelty Nobility Partner for Cell Line Development - Contract Pharma","headline":"AGC Biologics & Novelty Nobility Partner for Cell Line Development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9AFBVV95cUxQeGNGeHZGVUo4WVYtdHZISEQ2Nmk1a2Z6VWdUZS1ZSFVSQVM4UGZoYWVfSTZTcVRmUGRldzRaMjFLamxHc0QxOGIxRFhFLWlFc1B2N1l3OTFYMVFQRFdLUW5sSTlBazZ4Zks5cU9ucXV1b0FzR0EtT0RocWwzZjAzaFVlWmpQdHA3angxc3lMZjcyYlJkRTJoN0JoUkVSaVg3YVBIRE16YWhScDJxMlBpbDBoaUhIVTNyNC1XQ19NNldtV0dlVUtnVzlHTzlaU0Vtc1NORHFLVDk2bnp2YzVkRnR0QXF4LVVhM2piYXdXdXRmNFds?oc=5","date":"2025-05-06","type":"trial","source":"BioSpace","summary":"AGC Biologics Partners with Novelty Nobility for Cell Line Development and Phase I Preparations of Antibody Drug Candidate - BioSpace","headline":"AGC Biologics Partners with Novelty Nobility for Cell Line Development and Phase I Preparations of Antibody Drug Candida","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5TdXdUTmM5ZTY3aS14am9vTGtZUHcyZ2NPbDJBTU9BRWFXQmtJSjlHU0ZBZkktMnFCM2t3WWE1VkoybW1Xcng3ZmJ4OUlWMk0zTnRtbU1Id3JNQWEwZl9BT0xLcHJiMDA0d1V4MDRB0gFyQVVfeXFMTWdIZjRGRjc3SElvODVfSnhrUHFmbWhCSW1GVlh5ZEpDdnZwc045aFNHcDJGeHJ5U2FXZlZLT0JZZ241SVJ5MU1HR0xJWVFqc3F5UXJmeGFNZ1h3blZTbVZGVGdlbEJlV0VtOW9GNXlsQlp3?oc=5","date":"2025-04-21","type":"pipeline","source":"koreabiomed.com","summary":"Korean pharma acclerates TPD and DAC development amid global interest in new drug madalities - koreabiomed.com","headline":"Korean pharma acclerates TPD and DAC development amid global interest in new drug madalities","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxPV1FOTE9hQnllSnozakQ3VmtVU1J0dUtoZHp1Z0h3VWpKZkdZMUF6a254ZnJpUDJNaDlpZ3hyWm9sNUdGTEk5Rk9SY3pzX2l6SDZnZ0FNeVdQaThVbnU2SDgyWXV1VW1fcWNjeUdpdzJHVDJqalJRZXRuMnlGb1FnZEZIalBOdkVWSjRSNXpyM3JsUV90a1Bjc3JEcUpabW1ud1FveDJYanl4ZEE2elZYMjBlcw?oc=5","date":"2024-10-28","type":"deal","source":"Contract Pharma","summary":"GC Biopharma Partners with Novelty Nobility to Develop GA Treatment - Contract Pharma","headline":"GC Biopharma Partners with Novelty Nobility to Develop GA Treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBmSmR5ZGFMQXVTdzlTb1hKcnFBXzJtX2xUcjZDeEVTYi00SWJ5Vm5RYUNTWU8zRllyUi1YSy1GY2dOT2Ewd2JEWnZCcWFtemU0d0g2TnRNOURHbEFGQmhPNVQ2YnNYcG5WZDBMMzdB0gFyQVVfeXFMTUh3UUNBalM5M0gtR1NzeVh3THlfNkFtMk5oWkpKQkVfYU9lUlBDYndJUHg2VFJBRHVNMjlnYzNZRkFvTS1Wdk1lTDMtLVpkWHhHSkNkNEpwUWZ1S3JnTEs5NF9lNENQSDJjU0phX2VjVFZR?oc=5","date":"2023-02-13","type":"deal","source":"koreabiomed.com","summary":"Novelty Nobility’s auto-immune disease candidate NN2802 gets boost as U.S. partner acquired by Acelyrin - koreabiomed.com","headline":"Novelty Nobility’s auto-immune disease candidate NN2802 gets boost as U.S. partner acquired by Acelyrin","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBkMldFQWl2dXhabDloSmtPOWVHLVZUTW1qbUZwOWw0MmxLOXp6eTVNSUluYUdiYjBJT2JiQmZCOTU3OXJkeU1sRTBQVzNtRm0wQzF5aUkwUkFsakk5bkdELUl2ZFFUSjZTNFhwV0pR?oc=5","date":"2023-01-04","type":"pipeline","source":"KED Global","summary":"Samjin Pharm to undertake joint ADC R&D with Novelty Nobility - KED Global","headline":"Samjin Pharm to undertake joint ADC R&D with Novelty Nobility","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTE9jUW1QbTJQQVdIMERzNm55SGdTNWE3Z0ZnOGM0ZU4yRkJ2ekhBUjJPbURNNUFrOUk0d0tsMURwWVJ2ZGRQNnBoS0xEYWlUSll0QUJhbGEycFJDcGttOGNVZUxCUkxCZk5uWUJCMExROTMtQzdX?oc=5","date":"2022-03-17","type":"deal","source":"KED Global","summary":"Private equity consortium buys 30% stake in biotech firm Medipost - KED Global","headline":"Private equity consortium buys 30% stake in biotech firm Medipost","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZkFVX3lxTE9rakNFQVJ6WnAwR2YyZUdNMklKSVdYZzRUeUZBaDBDVzhRcTNfYWlHUkFDbjZvWFNxNDBWLUU5V1ZoT29yVVJ3Y1ZRdG1Eek9uVzJ4UktiWkZ1RGVqZl9OMTNyUUhlZw?oc=5","date":"2020-04-14","type":"pipeline","source":"AsiaTechDaily","summary":"Jin Cho, CFO Of Novelty Nobility Inc- Developing World-Class Therapeutics In Ophthalmology And Oncology - AsiaTechDaily","headline":"Jin Cho, CFO Of Novelty Nobility Inc- Developing World-Class Therapeutics In Ophthalmology And Oncology","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}